Insider · SEC Form 4 filer
Eric Weisblum
Past buys: 0 of 5 beat
Companies
Where they file as an insider
Silo Pharma (SILO) CEO, Director Latest filing Dec 15, 2025
Track record
Did their buys beat the typical stock?
Open-market buys31
Quarters checked 6 months later5
Beat the typical stock 0 of 5
Quarters too new to check0
0 of 5 checked quarters beat the typical stock. A past record is data, not a forecast.
Silo Pharma (SILO) Bought Nov 18–Dec 15, 2025 · $7.66K · 19,000 shares Not counted Not counted. We have no fund price for this stock on both Dec 31, 2025 and Jun 30, 2026.
Silo Pharma (SILO) Bought May 27, 2025 · $4.3K · 10,000 shares Behind typical Jun 30, 2025 $0.63 → Dec 31, 2025 $0.34 · −46.0% (typical stock +2.1%)
Silo Pharma (SILO) Bought Nov 20–Dec 13, 2024 · $6.72K · 7,500 shares Behind typical Dec 31, 2024 $0.89 → Jun 30, 2025 $0.63 · −29.2% (typical stock −3.4%)
Silo Pharma (SILO) Bought Apr 1–Jun 12, 2024 · $9.62K · 7,100 shares Behind typical Jun 30, 2024 $1.00 → Dec 31, 2024 $0.89 · −11.0% (typical stock +3.9%)
Silo Pharma (SILO) Bought Mar 28, 2024 · $6.61K · 3,408 shares Behind typical Mar 31, 2024 $1.95 → Sep 30, 2024 $1.10 · −43.6% (typical stock +3.2%)
Silo Pharma (SILO) Bought Nov 16–Dec 20, 2023 · $19.6K · 12,700 shares Behind typical Dec 31, 2023 $1.44 → Jun 30, 2024 $1.00 · −30.6% (typical stock −1.2%)
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.